StockGlow

Vitrolife AB (publ) (VITR.ST)

Makes equipment and supplies that help fertility doctors create embryos for people who can't conceive naturally.

86.70+0.00%Healthcare
Compare VITR.ST with
StockGlow Score
47
Neutral
BearishBullish
1 year ago-38.6%

The outlook

Vitrolife trades near its 52-week low with analyst consensus strongly bullish and an average price target around 49% above current levels. The stock sits below both its 50- and 200-day moving averages, reflecting a weak recent trend despite the optimistic analyst outlook.

What’s behind the score

Analyst consensusStrong Buy — 1.5 avg of 5 analysts
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Price targetAvg target +49% vs current price

Analyst price target

~12-month · 5 analysts
129.60average target+49.5% vs now
Now 86.70
Low 95.00High 155.00

Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.

Market cap
$11.74B
52-wk high
153.50
52-wk low
84.60
50-day avg
93.47
200-day avg
111.54
Trailing P/E
—

Similar stocks

SECT-B.STSectra AB (publ)$280.40+0.50%CEVI.STCellaVision AB (publ)$152.40+5.54%NIBE-B.STNIBE Industrier AB (publ)$37.67+0.11%GETI-B.STGetinge AB (publ)$233.90-0.55%THULE.STThule Group AB (publ)$224.20+0.27%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy